These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16042546)

  • 1. Involvement of presenilins in cell-survival signalling pathways.
    McCarthy JV
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):568-72. PubMed ID: 16042546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenilin function and gamma-secretase activity.
    Brunkan AL; Goate AM
    J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [beta-amyloid cascade: current status and future directions].
    Iwatsubo T
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1228-30. PubMed ID: 11464463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.
    Li YM
    Mol Interv; 2001 Oct; 1(4):198-207. PubMed ID: 14993342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
    Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
    J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
    Iwatsubo T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramembrane proteolysis by presenilins.
    Steiner H; Haass C
    Nat Rev Mol Cell Biol; 2000 Dec; 1(3):217-24. PubMed ID: 11252897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice.
    Tournoy J; Bossuyt X; Snellinx A; Regent M; Garmyn M; Serneels L; Saftig P; Craessaerts K; De Strooper B; Hartmann D
    Hum Mol Genet; 2004 Jul; 13(13):1321-31. PubMed ID: 15128703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Got RIP? Presenilin-dependent intramembrane proteolysis in growth factor receptor signaling.
    Landman N; Kim TW
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):337-51. PubMed ID: 15450250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
    Hoke DE; Tan JL; Ilaya NT; Culvenor JG; Smith SJ; White AR; Masters CL; Evin GM
    FEBS J; 2005 Nov; 272(21):5544-57. PubMed ID: 16262694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease. Closing in on gamma-secretase.
    De Strooper B
    Nature; 2000 Jun; 405(6787):627, 629. PubMed ID: 10864307
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.
    Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H
    Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation.
    Marambaud P; Robakis NK
    Genes Brain Behav; 2005 Apr; 4(3):134-46. PubMed ID: 15810902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation.
    Wang J; Beher D; Nyborg AC; Shearman MS; Golde TE; Goate A
    J Neurochem; 2006 Jan; 96(1):218-27. PubMed ID: 16305624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding partners of Alzheimer's disease proteins: are they physiologically relevant?
    Van Gassen G; Annaert W; Van Broeckhoven C
    Neurobiol Dis; 2000 Jun; 7(3):135-51. PubMed ID: 10860781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
    Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
    J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
    Iwatsubo T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presenilins as a marker of Alzheimer's disease].
    Scheper W; van Gool WA
    Ned Tijdschr Geneeskd; 1998 May; 142(22):1247-52. PubMed ID: 9749296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.